Related Experiment Video
Updated: Mar 8, 2026

12:37
Pharmacologic Induction of Epidermal Melanin and Protection Against Sunburn in a Humanized Mouse Model
Published on: September 7, 2013
18.9K
Melanoma and pregnancy.
Camilla Salvini1, Federica Scarfì2, Caterina Fabroni3
1Unit of Dermatology, USL Toscana Centro-Prato Hospital, Prato, Italy - camilla.salvini@ulscentro.toscana.it.
Summary
Melanoma incidence is rising, particularly in women of childbearing age. This review addresses controversies in melanoma diagnosis and management during pregnancy, aiding clinical decisions.
Area of Science:
- Oncology
- Dermatology
- Obstetrics & Gynecology
Background:
- Worldwide melanoma incidence is increasing, with a significant proportion affecting women of childbearing age.
- Malignant melanoma is the most common cancer diagnosed during pregnancy, highlighting the need for clear management guidelines.
Purpose of the Study:
- To review current knowledge and address controversies regarding melanoma in pregnant women.
- To provide guidance on diagnosis, staging, and treatment of melanoma during pregnancy.
- To clarify the impact of hormonal changes and pregnancy on melanoma prognosis and management.
Main Methods:
- Literature review of studies on melanoma and pregnancy.
- Analysis of controversial aspects including hormonal influences, staging, and treatment.
- Synthesis of information to aid clinical decision-making.
Main Results:
- The incidence and prognostic impact of pregnancy on melanoma remain unclear.
- Management of suspicious nevi requires careful evaluation and safe surgical intervention under local anesthesia.
- Treatment decisions in advanced melanoma during pregnancy necessitate a thorough risk-benefit analysis.
Conclusions:
- There is a lack of European guidelines for managing melanoma in pregnant women.
- Further research is needed to resolve controversies surrounding hormonal influences and pregnancy's impact on melanoma.
- This review aims to support clinicians in managing melanoma during pregnancy, considering both maternal and fetal well-being.
More Related Videos
Related Concept Videos
Skin Cancer
6.5K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
6.5K
Pigmentation
4.8K
The color of the skin is influenced by a number of pigments, including melanin, carotene, and hemoglobin. Recall that melanin is produced by cells called melanocytes, which are found scattered throughout the stratum basale of the epidermis. The melanin is transferred to the keratinocytes via melanosomes.
Melanin occurs in two primary forms: eumelanin that provides black and brown pigment and pheomelanin that provides red color. Dark-skinned individuals produce more melanin than those with pale...
Melanin occurs in two primary forms: eumelanin that provides black and brown pigment and pheomelanin that provides red color. Dark-skinned individuals produce more melanin than those with pale...
4.8K
Changes in Skin Color: Clinical Perspectives
4.0K
The first thing a clinician sees is the skin, so the examination of the skin should be part of any thorough physical examination. Most skin disorders are relatively benign, but a few, including melanomas, can be fatal if untreated. A couple of the more noticeable disorders, albinism and vitiligo, affect the appearance of the skin and its accessory organs.
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
4.0K
Mitral Valve Prolapse III: Nursing Management
498
The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
498
Teratogenicity
4.4K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.4K
Tumor Progression
7.7K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.7K

![Chemical-Induced Skin Carcinogenesis Model Using Dimethylbenz[a]Anthracene and 12-O-Tetradecanoyl Phorbol-13-Acetate DMBA-TPA](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F60445.jpg&w=3840&q=50)